Indehaveren af markedsføringstilladelsen (MAH) skal inden lanceringen af produktet sikre, at al sundhedspersonale, som forventes at skulle udskrive/ anvende RoActemra får udleveret undervisningsmateriale, der indeholder følgende:
The Marketing Authorisation Holder (MAH) shall ensure that, at launch, all healthcare professionals who are expected to prescribe/ use RoActemra are provided with educational materials containing the following: